Automatic Chlorination and Child Health in Urban Bangladesh

Not Applicable

Completed

• Conditions: Diarrhea; Communicable Diseases
• Interventions: Device: Water chlorination by the Flogenic; Device: Active control, vitamin C dosing into water

• Registration Number: NCT02606981
• Lead Sponsor: Stanford University

Brief Summary

Municipal water networks within industrialized countries typically rely on centralized treatment to manage piped water quality. Optimal water quality at the tap, however, requires well-maintained piped distribution networks, and performs best when piped systems are fully pressurized. In low-income cities such as Dhaka, water distribution networks are inadequately maintained and typically supply intermittent service; as such, they are vulnerable to recontamination during negative pressure events. Among populations accessing these types of improved water sources in urban settings (e.g. shared taps), it is unknown if consistent treatment to provide chlorinated water at the point of collection would have a significant health benefit. Furthermore, almost all previous studies of water treatment interventions in low-income countries have been unblinded with self-reported diarrhea as the main outcome, casting doubt that reported impacts of water disinfection on diarrhea are not due entirely to social desirability bias. Stanford University in collaboration with icddr,b will conduct a randomized evaluation to assess the impact on access to automatically chlorinated water on water quality and child health.

Detailed Description

Investigators will conduct a blinded cluster randomized controlled trial to evaluate the health and economic impacts of having access to automatically chlorinated water. The unit of randomization will be shared water points that typically serve 20-200 households. Shared water points connected to holding tanks compatible with the water treatment technology, and serving more than 4 households with at least one child under five, will be identified. Households accessing eligible water points as their primary drinking water source will be enrolled before installation of chlorine devices, and a baseline survey will be conducted of water quality, diarrhea prevalence, and health care expenditures. Following this baseline, households will be randomly assigned to control or treatment groups. The chlorination devices will be installed at the treatment group water points, while a doser containing vitamin C (and no chlorine), will be installed in the control group. The free chlorine dosing target will be below \<1ppm to preserve blinding. All households will be surveyed every 2-3 months for a total follow up period of 14-16 months (5-7 survey rounds, budget permitting).

Objectives:

1. To evaluate the impact of an automated chlorination system on microbial stored drinking water quality, residual chlorine, user satisfaction, user perceptions of water taste and smell, under-five child diarrhea (longitudinal prevalence) compared to a control group.

2. Compare the marginal additional cost (per person served) of installing and maintaining an automated chlorination system integrated with the current water supply infrastructure in low-income areas of Dhaka.

3. Assess the impact of an automated chlorination system on hospital visits and health care expenditures.

4. To measure secondary outcomes of the impact of an automated chlorination system including under-five child weight-for-age (WAZ), under-five height-for-age (HAZ), as well as levels of C-reactive protein and immunoglobin G in serum samples collected from children under five (these are objective indicators of infection, such as repeat diarrheal episodes).

Analysis:

The primary analyses will be intent-to-treat (investigators will analyze differences in outcomes between the treatment and control groups, with groups defined by their random allocation). Investigators will also conduct a secondary analysis comparing outcomes between intervention and control, where the intervention group is defined as those households that had free chlorine residual detected in their stored drinking water (treated on the treated analysis).

Study Timeline

• Study Start: 2015-07
• Study First Submitted: 2015-10-20
• Study First Submitted QC: 2015-11-16
• Study First Posted: 2015-11-17
• Primary Completion: 2016-12-20
• Study Completion: 2016-12-20
• Status Verified: 2017-05
• Last Update Submitted: 2017-05-10
• Last Update Posted: 2017-05-12

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 1549

Inclusion Criteria

• Households with at least one child under 60 months old
• Households using enrolled shared water point as primary drinking water source

Read More

Exclusion Criteria

• Households with a private drinking water source

Note: New births and children under 60 months that migrate into compounds accessing the enrolled water points for drinking water will be enrolled into the study.

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Chlorination	Water chlorination by the Flogenic	Device: Water chlorination by the Flogenic Primary drinking water source will be outfitted with automatic dosing device supplied with chlorine tablets. The device is called the Flogenic.
Control	Active control, vitamin C dosing into water	Active control: Vitamin C dosing into water. Primary drinking water source will be outfitted with automatic dosing device supplied with vitamin C tablets. The device is not commercially available.

Primary Outcome Measures

Name	Time	Method
Diarrhea longitudinal prevalence	Measured every 2-3 months for 16 months post baseline	1-week recall period, case definition is 3 or more loose/watery bowel movements in 24 hours

Secondary Outcome Measures

Name	Time	Method
Height-for-age-z-score	Measured at baseline and 16 months after baseline	Height-for-age z-score among children under five
Weight-for-age-z-score	Measured every 2-3 months for 16 months post baseline	Weight-for-age z-score among children under five years
Respiratory illness longitudinal prevalence	Measured every 2-3 months for 16 months post baseline	one week recall period, symptoms include congestion, cough, difficulty breathing
Prevalence and number of enteric pathogens	Measured 6-12 months after intervention delivery among children under five
Caregiver defined diarrhea	Measured every 2-3 months for 16 months post baseline	1-week recall period, defined with local Bengali word for diarrhea
C-reactive protein	Measured at baseline and conclusion of study (16 months post baseline) among children under five
total immunoglobin G (IgG)	Measured at baseline and conclusion of study (16 months post baseline) among children under five

Trial Locations

Locations (1)

Tongi and Dhaka Uddan; 🇧🇩 Tongi/Dhaka, Gazipur, Bangladesh